France-based Byome Labs secures €3.6M to scale its skin microbiome tech for personalised skincare
France-based deeptech startup Byome Labs has raised funding to advance its microbiome-based technology for personalised skincare.
Popular topics
Where the capital lands, who writes the cheque, and what gets built with it. Funding rounds, venture capital flows, and the deal-making that shapes which technology companies scale.
6,932 articles · Funding
France-based deeptech startup Byome Labs has raised funding to advance its microbiome-based technology for personalised skincare.
Paris-based Seyna, a company providing brokers with insurance products and technology specifically designed for their business, has secured €10M in a latest funding round, led by 115K, the investment fund of La Banque Postale.
French deeptech company Cailabs secures funding to support its growth, expand its operations, and continue developing its laser communication technologies.
Germany’s feld.energy closes seed funding to develop Agri-PV systems that allow farmers to grow crops and generate solar power on the same land.
The Dutch caretaker government announced that it is planning to invest over €500M in the country’s technology sector starting in 2026.
Thomas Beelaerts has announced his decision to step down as founder of Merqato, an AI-powered platform to optimise operational planning, marking the end of a 2.5-year journey with the company.
BRAINR has raised funding to expand internationally, advance its AI platform, and help more food producers digitise and manage their factory operations.
Vilnius-based MELP has raised fresh funding from a VC firm and business angels to expand its operations in the UK market.
Zurich-based Una Terra, a venture capital and growth equity platform, announced a €50M close of its Circular Economy Growth Fund.
Dutch biotech company Mevaldi has secured funding to scale its operations and move its bio-based products toward commercialisation.
Amsterdam-based Nebius Group, an AI infrastructure company, has announced the pricing of its offering of $2.75B in convertible senior notes.
Kópavogur, Iceland-based ORF Genetics, a plant biotechnology company, has raised €5M to expand its MESOkine growth-factor portfolio.